More Endobarrier data at the EASD

Russell Drummond (Honorary Meetings Secretary)
Date of the announcement: 
Friday, 4 November, 2016

The EASD in Munich was notable for two Endobarrier related events. There was a presentation of data on well over 200 patients from the German Endobarrier registry which confirmed the efficacy of this novel treatment for type 2 diabetes and obesity. See HERE.  
Secondly there was further presentation by Bob Ryder of the ABCD Endobarrier study (REVISE-Diabesity) which can be viewed HERE

Dr Russell Drummond. Principal Investigator. Glasgow Centre
ABCD REVISE-Diabesity Endobarrier Study 

Information for HCPs

COVID-19 Information for Healthcare Professionals